Zhuangzhuang Zheng
Overview
Explore the profile of Zhuangzhuang Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
389
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen R, Jiang Z, Wang H, Zheng Z, Jiang X
Mol Med
. 2025 Feb;
31(1):64.
PMID: 39972266
Radiotherapy is one of the most effective treatments for malignant tumors. Radioresistance is a major factor that contributes to radiotherapy failure and poor prognosis. Recent studies have elucidated the pivotal...
2.
Bian C, Zheng Z, Su J, Chang S, Yu H, Bao J, et al.
Front Pharmacol
. 2024 Nov;
15:1394754.
PMID: 39568579
Objectives: Literature data are scarce on concurrent chemoradiotherapy (CCRT) with S-1 for locally advanced nasopharyngeal carcinoma (LANPC) treatment. This study compared the efficacy and safety of the S-1 platinum-based CCRT...
3.
Zhang M, Zheng Z, Ding Q, Su J, Xin Y, Jiang X
Front Pharmacol
. 2024 Oct;
15:1458819.
PMID: 39474615
Background And Aims: Portal vein tumor thrombus (PVTT) occurs frequently in hepatocellular carcinoma (HCC) patients. However, there is currently no satisfactory treatment. Radiotherapy (RT) and tyrosine kinase inhibitors (TKI) are...
4.
Wang H, Zhang Q, Zheng Z, Xin Y, Jiang X
J Cell Mol Med
. 2024 Oct;
28(19):e70073.
PMID: 39397259
Human papillomavirus (HPV) infection is a causative factor in the occurrence and progression of oropharyngeal squamous cell carcinoma (OPSCC). In recent years, clinical studies have found that HPV-positive OPSCC patients...
5.
Shi W, Wang X, Liu S, Zheng Z, Dong L, Jiang X
Cancer Med
. 2024 Aug;
13(15):e7456.
PMID: 39118481
Objectives: High-grade gliomas (HGGs) are highly malignant, aggressive, and have a high incidence and mortality rate. The aim of this study was to investigate survival outcomes and prognostic factors in...
6.
Chang S, Lv J, Wang X, Su J, Bian C, Zheng Z, et al.
Crit Rev Oncol Hematol
. 2024 Aug;
202:104461.
PMID: 39103129
The treatment of thoracic tumors with ionizing radiation can cause radiation-induced lung injury (RILI), which includes radiation pneumonitis and radiation-induced pulmonary fibrosis. Preventing RILI is crucial for controlling tumor growth...
7.
Wei J, Chen Y, Su J, Zhao Q, Wang H, Zheng Z, et al.
Clin Nutr
. 2024 Jun;
43(7):1717-1723.
PMID: 38833872
Background & Aims: This study aims to observe the effects of early nutritional intervention on radiation-induced oral mucositis (OM) and the nutritional status of patients with head and neck cancer...
8.
Zheng Z, Shen Y, Su J, Ji X, Zhang Q, Zhao Q, et al.
Radiother Oncol
. 2024 Apr;
196:110285.
PMID: 38641258
Background And Purpose: Radiotherapy (RT) can damage neck vessels in patients with head and neck cancer (HNC). This study investigated the early effects of RT on carotid artery, including the...
9.
Wei J, Su J, Wang J, Jia X, Zhao Q, Shi W, et al.
Head Neck
. 2024 Jan;
46(4):915-925.
PMID: 38220218
Background: This study evaluated the efficacy of apatinib in maintenance therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Methods: Twenty-six patients from three centers were...
10.
Bao X, Zheng Z, Lv J, Bao J, Chang S, Jiang X, et al.
Front Pharmacol
. 2023 Nov;
14:1265571.
PMID: 38026972
Numerous studies have shown that neuroinflammation is involved in the process of neuronal damage in neurodegenerative diseases such as Parkinson's disease (PD), for example, and that inhibiting neuroinflammation help improve...